The intrinsic down-regulation of myostatin in atrophying DMD is speculated to counterbalance the muscle wasting progress, and this may explain the contradictory results in preclinical studies and human trials [56]. This evidence concerns the gene MSTN and Duchenne muscular dystrophy.